Strid Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Strid Group's LLY Position: Q2 2026 in Review
Strid Group reduced its Eli Lilly (LLY) stake by 4.5% in Q2 2026, selling an estimated $16.3K and leaving 337 shares worth $404K. The position accounts for 0.04% of the portfolio, ranked #61.
Strid Group first reported a position in LLY in Q4 2024 and has held it in 5 quarters since. 4,623 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Strid Group held 337 shares of Eli Lilly worth $404K as of Q2 2026.
- Strid Group sold 16 Eli Lilly shares in Q2 2026, an estimated $16.3K.
- Eli Lilly made up 0.04% of Strid Group's portfolio in Q2 2026, its #61 holding.
- Strid Group first reported a position in Eli Lilly in Q4 2024 and has held it in 5 quarters since.
- 4,623 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Strid Group's 13F filing for Q2 2026, filed 23 Jul 2026.